1. Home
  2. SBSW vs ABVX Comparison

SBSW vs ABVX Comparison

Compare SBSW & ABVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo D/B/A Sibanye-Stillwater Limited ADS

SBSW

D/B/A Sibanye-Stillwater Limited ADS

HOLD

Current Price

$13.19

Market Cap

8.8B

ML Signal

HOLD

Logo Abivax SA American

ABVX

Abivax SA American

HOLD

Current Price

$126.16

Market Cap

9.6B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
SBSW
ABVX
Founded
2013
2013
Country
South Africa
France
Employees
N/A
N/A
Industry
Precious Metals
Sector
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
8.8B
9.6B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SBSW
ABVX
Price
$13.19
$126.16
Analyst Decision
Buy
Strong Buy
Analyst Count
2
12
Target Price
$6.90
$112.83
AVG Volume (30 Days)
4.8M
1.7M
Earning Date
08-28-2025
08-11-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$6,290,132,787.00
$7,073,400.00
Revenue This Year
$14.61
$6.80
Revenue Next Year
$15.74
N/A
P/E Ratio
N/A
N/A
Revenue Growth
3.11
N/A
52 Week Low
$3.05
$4.77
52 Week High
$13.40
$138.49

Technical Indicators

Market Signals
Indicator
SBSW
ABVX
Relative Strength Index (RSI) 64.47 61.02
Support Level $12.10 $124.98
Resistance Level $12.81 $138.49
Average True Range (ATR) 0.52 6.98
MACD 0.05 0.25
Stochastic Oscillator 66.67 61.44

Price Performance

Historical Comparison
SBSW
ABVX

About SBSW D/B/A Sibanye-Stillwater Limited ADS

Sibanye Stillwater Ltd is a South African mining and metals processing group with a diverse portfolio of operations, projects, and investments across five continents. The Group is also one of the foremost recyclers of PGM autocatalysts and has interests in mine tailings retreatment operations. It is a producer of platinum, palladium, and rhodium and is a top-tier gold producer. It also produces and refines iridium and ruthenium, nickel, chrome, copper, and cobalt. Its products are Gold, Nickel, Zinc, Chrome, PGMs, and other.

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.

Share on Social Networks: